Annual report
2385.TEDINET S100RWNQ
Period2022-07-01 → 2023-06-30
Filed2023-09-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.1bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥9.3bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥8.9bn | 2020-07-01 → 2021-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.3bn | 2019-07-01 → 2020-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.6bn | 2018-07-01 → 2019-06-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥726m | 2022-07-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥1.2bn | 2021-07-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥727m | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥920m | 2020-07-01 → 2021-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2019-07-01 → 2020-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥878m | 2018-07-01 → 2019-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥725m | 2022-07-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.3bn | 2021-07-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥452m | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥810m | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥562m | 2020-07-01 → 2021-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥732m | 2019-07-01 → 2020-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥553m | 2018-07-01 → 2019-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥456m | 2022-07-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥817m | 2021-07-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥8.2bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥8.5bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥7.1bn | at 2021-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.4bn | at 2020-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥6.3bn | at 2019-06-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.1bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥1.6bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥7.2bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥6.8bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥6.2bn | at 2021-06-30d | Cons. | Net assets |
| Net assets / equity | ¥5.8bn | at 2020-06-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥5.2bn | at 2019-06-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.9bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.0bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.9bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.3bn | at 2021-06-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.5bn | at 2020-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.1bn | at 2019-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥102m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥107m | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥830m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥469m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥160m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥245m | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥25m | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥693m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥289m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥130m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥130m | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥131m | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥103m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥52m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥17.27 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.95 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.49 | 2020-07-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.97 | 2019-07-01 → 2020-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.16 | 2018-07-01 → 2019-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥266.41 | at 2023-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥254.14 | at 2022-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥230.88 | at 2021-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥214.39 | at 2020-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥190.87 | at 2019-06-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 84.6% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.5% | at 2021-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.7% | at 2020-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.5% | at 2019-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.6% | 2022-07-01 → 2023-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.8% | 2021-07-01 → 2022-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.7% | 2020-07-01 → 2021-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.8% | 2019-07-01 → 2020-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.7% | 2018-07-01 → 2019-06-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 98 | at 2023-06-30 | Cons. | Number of employees |
| Employees | 100 | at 2022-06-30 | Cons. | Number of employees |
| Employees | 104 | at 2021-06-30d | Cons. | Number of employees |
| Employees | 105 | at 2020-06-30d | Cons. | Number of employees |
| Employees | 101 | at 2019-06-30d | Cons. | Number of employees |
| Revenue | ¥377m | 2022-07-01 → 2023-06-30 | Standalone | Net sales |
| Revenue | ¥439m | 2021-07-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥425m | 2020-07-01 → 2021-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥425m | 2019-07-01 → 2020-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥303m | 2018-07-01 → 2019-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥81m | 2022-07-01 → 2023-06-30 | Standalone | Operating income |
| Operating income | ¥134m | 2021-07-01 → 2022-06-30 | Standalone | Operating income |
| Ordinary income | ¥87m | 2022-07-01 → 2023-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥137m | 2021-07-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥132m | 2020-07-01 → 2021-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥116m | 2019-07-01 → 2020-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥73m | 2018-07-01 → 2019-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥87m | 2022-07-01 → 2023-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥137m | 2021-07-01 → 2022-06-30 | Standalone | Income before income taxes |
| Net income | ¥142m | 2022-07-01 → 2023-06-30 | Standalone | Profit loss |
| Net income | ¥195m | 2021-07-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | ¥288m | 2020-07-01 → 2021-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥155m | 2019-07-01 → 2020-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥111m | 2018-07-01 → 2019-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.3bn | at 2023-06-30 | Standalone | Assets |
| Total assets | ¥4.5bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥4.2bn | at 2021-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.1bn | at 2020-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.0bn | at 2019-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥21m | at 2023-06-30 | Standalone | Liabilities |
| Total liabilities | ¥196m | at 2022-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥4.3bn | at 2023-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.3bn | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.2bn | at 2021-06-30d | Standalone | Net assets |
| Net assets / equity | ¥4.1bn | at 2020-06-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.0bn | at 2019-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2023-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2022-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥5.44 | 2022-07-01 → 2023-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.47 | 2021-07-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.02 | 2020-07-01 → 2021-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.91 | 2019-07-01 → 2020-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.26 | 2018-07-01 → 2019-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥5 | 2022-07-01 → 2023-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2021-07-01 → 2022-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2020-07-01 → 2021-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2019-07-01 → 2020-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥4 | 2018-07-01 → 2019-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥163.95 | at 2023-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥163.52 | at 2022-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥161.05 | at 2021-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥155.03 | at 2020-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥153.56 | at 2019-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 99.5% | at 2023-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.6% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.5% | at 2021-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.6% | at 2020-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.3% | at 2019-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 3.3% | 2022-07-01 → 2023-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.6% | 2021-07-01 → 2022-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.0% | 2020-07-01 → 2021-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2019-07-01 → 2020-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2018-07-01 → 2019-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 26,158,200 | at 2023-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 26,158,200 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 26,158,200 | at 2021-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 26,158,200 | at 2020-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 26,158,200 | at 2019-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 7 | at 2023-06-30 | Standalone | Number of employees |
| Employees | 9 | at 2022-06-30 | Standalone | Number of employees |
| Employees | 8 | at 2021-06-30d | Standalone | Number of employees |
| Employees | 8 | at 2020-06-30d | Standalone | Number of employees |
| Employees | 7 | at 2019-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 92
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-07-01 → 2023-06-30 | ¥244,000 |
| Reconciling Itemsreconciling | depreciation | 2022-07-01 → 2023-06-30 | ¥217,000 |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-06-30 | −¥25m |
| Reconciling Itemsreconciling | revenue external | 2022-07-01 → 2023-06-30 | ¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment assets | at 2023-06-30 | ¥1.5bn |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-06-30 | −¥294m |
| Clinical Evidence Servicereportable segment | capex | 2022-07-01 → 2023-06-30 | ¥8m |
| Clinical Evidence Servicereportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥4m |
| Clinical Evidence Servicereportable segment | employees | at 2023-06-30 | 20 pure |
| Clinical Evidence Servicereportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥617m |
| Clinical Evidence Servicereportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥602m |
| Clinical Evidence Servicereportable segment | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥15m |
| Clinical Evidence Servicereportable segment | segment assets | at 2023-06-30 | ¥427m |
| Clinical Evidence Servicereportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥89m |
| Functional Cosmetic Retailingreportable segment | capex | 2022-07-01 → 2023-06-30 | ¥29m |
| Functional Cosmetic Retailingreportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥13m |
| Functional Cosmetic Retailingreportable segment | employees | at 2023-06-30 | 29 pure |
| Functional Cosmetic Retailingreportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥3.9bn |
| Functional Cosmetic Retailingreportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥3.9bn |
| Functional Cosmetic Retailingreportable segment | segment assets | at 2023-06-30 | ¥3.3bn |
| Functional Cosmetic Retailingreportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥658m |
| Functional Food Retailingreportable segment | capex | 2022-07-01 → 2023-06-30 | ¥3m |
| Functional Food Retailingreportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥5m |
| Functional Food Retailingreportable segment | employees | at 2023-06-30 | 25 pure |
| Functional Food Retailingreportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥2.5bn |
| Functional Food Retailingreportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥2.5bn |
| Functional Food Retailingreportable segment | segment assets | at 2023-06-30 | ¥1.3bn |
| Functional Food Retailingreportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥137m |
| Functional Material Developmentreportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥1m |
| Functional Material Developmentreportable segment | employees | at 2023-06-30 | 9 pure |
| Functional Material Developmentreportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥501m |
| Functional Material Developmentreportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥490m |
| Functional Material Developmentreportable segment | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥11m |
| Functional Material Developmentreportable segment | segment assets | at 2023-06-30 | ¥1.4bn |
| Functional Material Developmentreportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥43m |
| Health Care Support Servicereportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥935,000 |
| Health Care Support Servicereportable segment | employees | at 2023-06-30 | 8 pure |
| Health Care Support Servicereportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥553m |
| Health Care Support Servicereportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥553m |
| Health Care Support Servicereportable segment | segment assets | at 2023-06-30 | ¥315m |
| Health Care Support Servicereportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥93m |
| —segment total | capex | 2022-07-01 → 2023-06-30 | ¥39m |
| —segment total | depreciation | 2022-07-01 → 2023-06-30 | ¥25m |
| —segment total | revenue | 2022-07-01 → 2023-06-30 | ¥8.1bn |
| —segment total | revenue external | 2022-07-01 → 2023-06-30 | ¥8.1bn |
| —segment total | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥26m |
| —segment total | segment assets | at 2023-06-30 | ¥6.8bn |
| —segment total | segment profit | 2022-07-01 → 2023-06-30 | ¥1.0bn |
| Reconciling Itemsreconciling | depreciation | 2021-07-01 → 2022-06-30 | ¥237,000 |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2022-06-30 | −¥9m |
| Reconciling Itemsreconciling | revenue external | 2021-07-01 → 2022-06-30 | ¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2022-06-30 | −¥11m |
| Reconciling Itemsreconciling | segment assets | at 2022-06-30 | ¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-06-30 | −¥304m |
| Clinical Evidence Servicereportable segment | capex | 2021-07-01 → 2022-06-30 | ¥5m |
| Clinical Evidence Servicereportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥2m |
| Clinical Evidence Servicereportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥552m |
| Clinical Evidence Servicereportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥552m |
| Clinical Evidence Servicereportable segment | segment assets | at 2022-06-30 | ¥453m |
| Clinical Evidence Servicereportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥6m |
| Functional Cosmetic Retailingreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥5m |
| Functional Cosmetic Retailingreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥11m |
| Functional Cosmetic Retailingreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥5.0bn |
| Functional Cosmetic Retailingreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥5.0bn |
| Functional Cosmetic Retailingreportable segment | segment assets | at 2022-06-30 | ¥3.7bn |
| Functional Cosmetic Retailingreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥1.1bn |
| Functional Food Retailingreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥34m |
| Functional Food Retailingreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥3m |
| Functional Food Retailingreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥2.7bn |
| Functional Food Retailingreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥2.7bn |
| Functional Food Retailingreportable segment | segment assets | at 2022-06-30 | ¥1.3bn |
| Functional Food Retailingreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥200m |
| Functional Material Developmentreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥2m |
| Functional Material Developmentreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥569m |
| Functional Material Developmentreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥558m |
| Functional Material Developmentreportable segment | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥11m |
| Functional Material Developmentreportable segment | segment assets | at 2022-06-30 | ¥1.3bn |
| Functional Material Developmentreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥83m |
| Health Care Support Servicereportable segment | capex | 2021-07-01 → 2022-06-30 | ¥709,000 |
| Health Care Support Servicereportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥1m |
| Health Care Support Servicereportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥549m |
| Health Care Support Servicereportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥549m |
| Health Care Support Servicereportable segment | segment assets | at 2022-06-30 | ¥330m |
| Health Care Support Servicereportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥117m |
| —segment total | capex | 2021-07-01 → 2022-06-30 | ¥45m |
| —segment total | depreciation | 2021-07-01 → 2022-06-30 | ¥20m |
| —segment total | revenue | 2021-07-01 → 2022-06-30 | ¥9.4bn |
| —segment total | revenue external | 2021-07-01 → 2022-06-30 | ¥9.3bn |
| —segment total | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥11m |
| —segment total | segment assets | at 2022-06-30 | ¥7.2bn |
| —segment total | segment profit | 2021-07-01 → 2022-06-30 | ¥1.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,234
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets | CurrentYearInstant_NonConsolidatedMember_LegalCapitalSurplusMember | 1931477000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_CapitalSurplusMember | 1931477000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_GeneralReserveMember | 10000000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_RetainedEarningsBroughtForwardMember | 510684000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_RetainedEarningsMember | 520684000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember | 4288748000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember | 4277336000 | JPY |
| Dividends from surplus | CurrentYearDuration_NonConsolidatedMember | -130791000 | JPY |
| Profit loss | CurrentYearDuration_NonConsolidatedMember | 142203000 | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember | 11412000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember | 4288748000 | JPY |
| Directors compensations sga | Prior1YearDuration_NonConsolidatedMember | 91108000 | JPY |
| Directors compensations sga | CurrentYearDuration_NonConsolidatedMember | 91408000 | JPY |
| Salaries and allowances sga | Prior1YearDuration_NonConsolidatedMember | 76045000 | JPY |
| Salaries and allowances sga | CurrentYearDuration_NonConsolidatedMember | 64504000 | JPY |
| Depreciation sga | Prior1YearDuration_NonConsolidatedMember | 237000 | JPY |
| Depreciation sga | CurrentYearDuration_NonConsolidatedMember | 217000 | JPY |
| Commission fee sga | Prior1YearDuration_NonConsolidatedMember | 87234000 | JPY |
| Commission fee sga | CurrentYearDuration_NonConsolidatedMember | 85221000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-09-28 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第29期（自 2022年７月１日 至 2023年６月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社総医研ホールディングス | |
| Company name in english cover page | FilingDateInstant | Soiken Holdings Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 石神 賢太郎 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)大阪府豊中市新千里東町一丁目４番２号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 06（6871）8888 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)財務部長 奥野 貴人 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)大阪府豊中市新千里東町一丁目４番２号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 06（6871）8888 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)財務部長 奥野 貴人 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E05367 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 23850 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社総医研ホールディングス | |
| Filer name in english | FilingDateInstant | Soiken Holdings Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2022-07-01 | |
| Current period end date | FilingDateInstant | 2023-06-30 | |
| Type of current period | FilingDateInstant | FY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |